| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 1.2K | 0.2% | 17.4% |
| Total Income | 1.2K | 0.4% | 17.2% |
| Expenditure | 1.2K | 0.0% | 22.1% |
| PBT | 50.57 | 7.5% | 38.9% |
| Net Profit | 36.59 | 10.0% | 44.3% |
| OPM | 5.36% | 0.06pp | 3.75pp |
| NPM | 3.03% | 0.32pp | 3.34pp |
| EPS | 6.06 | 10.1% | 44.4% |
Detailed report is being prepared.
Can Dodla Stabilize Margins After Q1's Squeeze?
Revenue likely to track the upgrade trajectory, but the Street will be watching whether margin pressure from milk cost inflation proves transient or structural.
The Setup: Revenue vs. Profitability
Dodla Dairy's Q1 FY27 results painted a tale of two halves. Highest-ever quarterly revenue of ₹1,197.9 Cr (+19% YoY) and record milk procurement signalled robust operational momentum. Yet consolidated PAT crashed 35% YoY to ~₹41 Cr, compressing net margin from 6.1% a year ago to just 3.4% — the sharpest squeeze in recent quarters. The culprit: a sharp spike in raw milk procurement costs that outpaced the company's ability to push through price increases in the near term.
For Q2 FY27, the central question is whether this margin pressure proves transient (a seasonal milk-cost spike that reverses with supply normalization) or structural (a new baseline cost reality that forces a renegotiation of pricing power and product mix). The Street remains constructive — 4 analysts polled rate the stock a Strong Buy with an average 12-month target of ₹1,293 — but all eyes will be on the PAT line on Oct 28.
~₹1,160–1,200 Cr
Consistent with Q1 growth trajectory (+18–22% YoY); volume momentum intact
3.5–4.5% vs. 3.4% in Q1
Critical swing factor; recovery from Q1 lows or further compression signals structural vs. cyclical pressure
~19.0–19.5 LLPD
Volume growth driver; up ~13% YoY in prior quarter; any slowdown would flag demand softness
6.08% (Q1 FY27)
Declining from 10.03% a year ago — foreign money rotating away amid margin concerns
What a Strong vs. Weak Print Looks Like
Strong: Revenue ₹1,180+ Cr (+19%+ YoY) with PAT margin recovering to 4%+ (₹47+ Cr profit). This would signal that milk cost inflation is being managed through a mix of cost controls, product mix (higher-margin value-added items), and moderate price realization gains. Guidance affirmed and confidence in H2 stability. Weak: Revenue in line but PAT margin staying at 3.4% or deteriorating further; cost of raw milk remains sticky. This would signal pricing power is limited and operational leverage is turning negative. Any margin guidance cut or cautious commentary on H2 would trigger a sharp sell-off.
Street Consensus & Recent Rating Action
Since Last Quarter: The Filings Scan
Oct 18: Dodla issued a clarification regarding an FSSAI regulatory matter at its Batlagundu plant. The company addressed media articles and FSSAI social media posts without providing detailed remedial steps. This remains a red flag — regulatory clarity ahead of the result would be welcome. Oct 1: Dodla completed a 2% stake acquisition in Sids Farm Private Limited for ~₹11.6 Cr. A modest inorganic move, likely aimed at vertical integration or supply-chain optionality in a volatile milk-cost environment. Aug 5: DSP Mutual Fund increased its stake to 7.16%, suggesting institutional confidence despite recent volatility. Sep 24: Trading window closure (effective Oct 1 through 48 hours post-result) — routine, but note that promoter buying/selling is blocked until after the result is announced.
Price & Trend Context
DODLA trades at ₹974.2, down 36% from its ATH of ₹1,525 and below all major moving averages (SMA20: ₹1,004, SMA50: ₹1,054, SMA200: ₹1,092). RSI at 37 signals oversold conditions, yet volume is increasing — a potential reversal setup if margins stabilize. FII ownership has contracted sharply from 10% a year ago to 6%, reflecting foreign rotation away from margin-compression trades. A strong Q2 result with recovered PAT margin and positive H2 guidance could catalyze a relief rally back toward the ₹1,200+ level.
1 · PAT Margin: Stabilization or Deterioration?
If Q2 PAT margin recovers toward 4%+ (vs. Q1's 3.4%), it signals milk costs are normalizing and pricing is kicking in. Anything below 3.5% with a cautious tone on H2 would be a red flag for structural margin compression.
2 · FSSAI Clarity
What was the Batlagundu plant issue, and how is it being remediated? Any regulatory risk that could impact milk procurement, capacity, or reputation?
3 · H2 FY27 Guidance
Will management affirm FY27 full-year revenue and margin targets, or pull back? This will determine whether the Street's 33% upside call to ₹1,293 is justified.
Dodla Dairy enters Q2 FY27 with strong revenue momentum but under margin pressure. The Street is confident in a recovery, but the data will tell. Expect ₹1,160–1,200 Cr revenue in line with trajectory, but watch whether PAT margin stabilizes above 4% or stays pinned at Q1's stressed 3.4%. FSSAI regulatory clarity is a secondary but material item. If the company delivers margin recovery, H2 confidence, and clear guidance, the oversold setup (down 36% from ATH, RSI 37, foreign money fleeing) could reverse sharply toward ₹1,200+. If margins continue to compress or guidance turns cautious, the sell-off could deepen.